doi: 10.3389/fmolb.2026.1804435 Received 05 February 2026 Revised 02 March 2026 Accepted 03 March 2026 Published 23 March 2026 Volume 13 - 2026 Edited by Claudia Fiorillo, University of Florence, Italy Reviewed by Gloria Riitano, Sapienza University of Rome, Italy Sanjit Roy, Glycomontra, Inc., United States Updates Copyright 2026 Shi, Qi, Xue, Zhang, Mu, Wang, Zhu, Kong and Han
Learn more about the roles of glycine and conjugated bile acids in complex chronic diseases such as cancer, Alzheimers disease, depression, inflammatory bowel disease, multiple sclerosis and diabetes in our whitepaper Complex chronic diseases have a common origin
2022;193(Pt 1):20212
The effect is likely modest compared to pharmaceutical GLP-1 agonists, but it exists
Reductions in the mitochondrial enzyme -ketoglutarate dehydrogenase complex in neurodegenerative disease - beneficial or detrimental